Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 33NIH 5INDUSTRY 3NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 15Prostatic Neoplasms 14Neoplasms 12Lung Neoplasms 8Colonic Neoplasms 7Colonic Polyps 5Pulmonary Disease, Chronic Obstructive 4Heart Failure 4Urinary Incontinence 2Smoking Cessation 2Patient Preference 2Pain 2Lung Diseases 2Deglutition Disorders 2Death 2Chronic Disease 2Breast Neoplasms 2Adenomatous Polyps 2Adenoma 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Use 1Tobacco Smoking 1Stress Disorders, Post-Traumatic 1Smoking Reduction 1Skin Neoplasms 1Skin Diseases 1Respiratory Aspiration 1Renal Insufficiency, Chronic 1

Interventions

Celecoxib 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Has results × Mouth Neoplasms × Clear all
NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

VA Office of Research and Development

Phase 1/2 Completed
21 enrolled 10 charts
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡